newsfilter
← Latest News
GlobeNewswire·

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • TELA Bio's Compensation Committee approved inducement grants of restricted stock units covering 108,550 shares for four newly-hired employees.
  • The grants were dated November 4, 2026, & issued under Nasdaq Rule 5635(c)(4) as an inducement for employment acceptance.
  • Grants totaling 58,550 shares will vest in equal annual installments over four years, contingent on continued service.
  • A grant of 50,000 shares will vest 100% on the first anniversary of the grant date, subject to continued service.
  • TELA Bio is a commercial-stage medical technology company focused on soft-tissue reconstruction solutions that prioritize patient anatomy preservation.
Company
Tela Bio Inc
Keywords
Nasdaq:TELA, Tela Bio Inc